1. USP Chapters <1086> Impurities in drug substances and drug products. USP 41. The United States Pharmacopeial Convention. August 1, 2018
2. ICH Harmonised Tripartite Guideline. Impurities in new drug substances. Q3A(R2). ICH. 25 October 2006
3. ICH Harmonised Tripartite Guideline. Impurities in new drug products. Q3B(R2). ICH. 2 June 2006
4. Crowley P, Martini LG. Drug-excipient interactions. Pharmaceutical Technology. 2001;13:26-34
5. Bharate SS, Bharate SB, Bajaj AN. Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: A comprehensive review. Journal of Excipients and Food Chemicals. 2010;1(3):3-26